TABLE 3.
Serogroup | Age group (mo) | Prevaccination
|
1 mo postvaccination
|
||
---|---|---|---|---|---|
No. | GMC (μg/ml) (95% confidence interval) | No. | GMC (μg/ml) (95% confidence interval) | ||
A | 6 | 43 | 2.4 (1.8-3.1) | 44 | 4.1 (3.1-5.5) |
12 | 46 | 1.9 (1.4-2.5) | 44 | 7.5 (5.2-11.0) | |
18 | 49 | 2.9 (2.4-3.5) | 49 | 9.5 (6.7-13.5) | |
24 | 68 | 1.6 (1.2-2.1) | 67 | 7.3 (4.9-10.8) | |
36 | 78 | 2.6 (1.9-3.4) | 77 | 10.9 (7.7-15.3) | |
48 | 93 | 2.6 (2.1-3.2) | 92 | 10.4 (7.8-13.8) | |
C | 6 | 43 | 1.9 (1.4-2.6) | 44 | 2.8 (2.3-3.4) |
12 | 46 | 1.9 (1.4-2.5) | 46 | 3.4 (2.7-4.3) | |
18 | 49 | 2.3 (1.8-2.9) | 49 | 3.4 (2.7-4.3) | |
24 | 68 | 1.7 (1.4-2.0) | 67 | 3.0 (2.5-3.8) | |
36 | 78 | 1.9 (1.6-2.3) | 77 | 2.4 (1.8-3.2) | |
48 | 92 | 2.0 (1.7-2.4) | 91 | 3.4 (2.7-4.2) | |
W135 | 6 | 43 | 1.0 (0.7-1.3) | 44 | 1.3 (1.0-1.6) |
12 | 46 | 0.9 (0.7-1.2) | 46 | 1.7 (1.4-2.3) | |
18 | 49 | 0.9 (0.7-1.1) | 49 | 1.7 (1.4-2.1) | |
24 | 68 | 0.7 (0.6-0.9) | 68 | 1.6 (1.3-2.1) | |
36 | 78 | 0.9 (0.8-1.1) | 77 | 1.8 (1.3-2.3) | |
48 | 93 | 0.9 (0.8-1.2) | 93 | 2.2 (1.6-2.9) | |
Y | 6 | 43 | 0.4 (0.2-0.5) | 43 | 0.6 (0.5-0.8) |
12 | 46 | 0.3 (0.2-0.5) | 46 | 0.7 (0.5-0.9) | |
18 | 49 | 0.4 (0.3-0.5) | 49 | 0.9 (0.7-1.1) | |
24 | 68 | 0.3 (0.2-0.3) | 66 | 1.1 (0.8-1.6) | |
36 | 78 | 0.4 (0.3-0.4) | 77 | 1.1 (0.8-1.6) | |
48 | 93 | 0.4 (0.3-0.5) | 92 | 2.0 (1.4-2.9) |